Post by NFA on May 21, 2021 17:13:17 GMT 8
Don't tell Fauci: More evidence for ivermectin
By James V. DeLong May 21, 2021
www.americanthinker.com/blog/2021/05/dont_tell_fauci_more_evidence_for_ivermectin.html
By James V. DeLong May 21, 2021
www.americanthinker.com/blog/2021/05/dont_tell_fauci_more_evidence_for_ivermectin.html
Dr. Pierre Kory and his colleagues at the Front Line COVID-19 Critical Care Alliance (FLCCC) are leading an effort to assess the effectiveness of ivermectin as a prophylactic against and treatment for COVID and to communicate to the public the mounting evidence of its efficacy. (Ivermectin is well known as an anti-parasitic, and millions of doses are distributed annually in complete safety.)
Kory recently published two important papers.
The first, in the May–June issue of the peer-reviewed American Journal of Therapeutics, is "Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19." Its conclusions, backed by rigorous consideration of bountiful evidence, are as follows:
......
The psychological barriers to accepting FLCCC's analyses are strong, because it strains credulity to believe that the public health authorities, Big Pharma, and our political overlords are so divorced from reality and morality as to reject a well known and quite safe life-saving drug. But a great deal of current public policy, ranging from climate change to gender identity to election integrity to foreign policy, bears little connection to reality, and the powers that be are under heavy financial and reputational pressure to deny ivermectin.
So one should read the papers and decide for oneself.
Kory recently published two important papers.
The first, in the May–June issue of the peer-reviewed American Journal of Therapeutics, is "Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19." Its conclusions, backed by rigorous consideration of bountiful evidence, are as follows:
Meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 have found large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance. Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with regular use of ivermectin. Finally, the many examples of ivermectin distribution campaigns leading to rapid population-wide decreases in morbidity and mortality indicate that an oral agent effective in all phases of COVID-19 has been identified.
The psychological barriers to accepting FLCCC's analyses are strong, because it strains credulity to believe that the public health authorities, Big Pharma, and our political overlords are so divorced from reality and morality as to reject a well known and quite safe life-saving drug. But a great deal of current public policy, ranging from climate change to gender identity to election integrity to foreign policy, bears little connection to reality, and the powers that be are under heavy financial and reputational pressure to deny ivermectin.
So one should read the papers and decide for oneself.
